For 2025 we have developed a new format focusing on cell- and gene therapies (CGT) targeting cancer. A group of distinguished international experts will share their perspectives on emerging science and how to accelerate the path towards clinical implementation. The panel will focus on novel partnerships addressing existing hurdles and pave the way for effective and affordable treatments. This will be followed by a pitch session with up to 10 emerging CGT companies from European and US hubs will present their technologies and assets, and receive expert feedback they can build on.